Search results for: 'textile working systems'

This research service provides the market revenues and trends of various breast imaging modalities in the Chinese market. Increasing incidence of breast cancer, awareness among the population, healthcare reforms, and expansion of breast screening to rural areas accelerate the growth of breast imaging market in China. Increasing disposable income, ...

The 20th annual World Diabetes Congress of the International Diabetic Federation mentions that India leads the world in the looming epidemic of diabetes. The concept of Self-Monitoring of Blood Glucose (SMBG) was introduced in India only a few years back, and the industry has already grown to about $49.7 million with a growth rate of over 20 per...

Southeast Asia (SEA) is emerging as the gold mine for both local and international healthcare vendors. Within SEA, Malaysia, Singapore, and Indonesia still have unexplored and under-served markets providing boundless opportunities for healthcare vendors with innovative products and services. To be able to capitalize on the market, medical device ma...

The report provides an overview of the Russian Hospital system, listing key regions and their hospitals landscapes. Key hospitals have been profiled for the regions, with details about their infrastructure, patient trends, department trends, and other relevant information. The regions selected include Moscow, St. Petersburg, Tyumen, Krasnodar, and ...

12 Jul 2016  |  Asia Pacific  |  Market Research

Analysis of the APAC Health Information Exchange Market

 

Infographics

×

This research service analyzes the health information exchange (HIE) market in Asia-Pacific. Driven primarily by governments, the region is embarking on the next phase of healthcare IT transformation, investing in decentralizing patient information by enabling data exchange among established electronic medical record (EMR) and electronic health rec...

Chinese healthcare industry witnessed one of the fastest growths in the world in the last two decades. The growth of the healthcare industry was mainly driven by globalization initiatives and increased domestic and foreign investment after WTO accession. The government is continuously working to reform the health sector and healthcare development i...

More than 6,000 molecules are currently in clinical development across the pharmaceutical research and development (R&D) landscape, with more than 11,000 in the preclinical phase. The industry is witnessing the growth of small- to mid-segment pharma/biotech players making significant contributions to drug discovery and development pipelines. Across...

With over-4000 pharmaceutical players, China is the second largest pharmaceutical industry globally. Although highly fragmented, global pharma and biopharmaceutical players such as Novartis, Novo Nordisk, and AstraZeneca, have a significant hold capturing at least 8-10Percentage of the market. The market being highly dependent on its distributor ne...

The healthcare expenditure in Australia in the previous financial year was AUD 170.4 billion, with 10.3% of the gross domestic product (GDP), thereby allowing the country’s healthcare spending to pass the 10% mark for the first time. Healthcare expenditure continues to rise; however, the rate of increase has been curbed in the last few years. At AU...